Home » Authors » James Etheridge

Articles by James Etheridge

Cerep Completes Drug Target Validation Under 1999 BMS Deal

May 8, 2002

By James Etheridge

Genset Prepares To Initiate Clinical Trials Of Famoxin

May 1, 2002

By James Etheridge

Genset Prepares To Initiate Clinical Trials Of Famoxin

May 1, 2002

By James Etheridge

Faust Pharmaceuticals Obtains $2.6M To Develop CNS Drugs

April 24, 2002

By James Etheridge

Faust Pharmaceuticals Obtains $2.6M To Develop CNS Drugs

April 24, 2002

By James Etheridge

Hybrigenics Raises $14.8M In Third Funding Round

April 17, 2002

By James Etheridge

Start-Up CareX Raises $5.2M In Initial Funding Round

April 17, 2002

By James Etheridge

Start-Up CareX Raises $5.2M In Initial Funding Round

April 17, 2002

By James Etheridge

Hybrigenics Raises $14.8M In Third Funding Round

April 17, 2002

By James Etheridge

Evologic Uses Forced Evolution To Create Microbial Organisms

April 10, 2002

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...